Aims: Although rheumatic diseases constitute a leading cause of disability, the environmental risk factors for these diseases are not clarified. In the present study, we aim to systematically appraise the epidemiological credibility of the environmental risk factors for rheumatic diseases.
associations for rheumatic diseases has been advanced by the conduct of genomewide association studies, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] there is still a knowledge gap in the understanding of the environmental risk factors for rheumatic diseases. 1 Multiple environmental factors are considered to contribute to the development of rheumatic diseases and several environmental exposures have been proposed in published metaanalyses, including dietary factors, smoking, hormonal factors, and physical trauma. 20 However, to our knowledge, there has been no systematic effort to summarize the existing evidence from these meta-analyses and to examine their potential limitations. In the present study, our aim is to map the range and the validity of environmental risk factors for rheumatic diseases by evaluating the presence and the extent of potential biases in this literature. We also assess which of these associations present strong epidemiological credibility.
| ME TH ODS
We conducted an umbrella review, which is a systematic collection and assessment of multiple systematic reviews and meta-analyses on a specific research topic. 21 The methods of the umbrella review are standardized, and we followed state-of-the-art approaches as previously published umbrella reviews on risk factors for other chronic medical conditions. [22] [23] [24] [25] [26] [27] [28] [29] A protocol of this umbrella review has been submitted to PROSPERO (registration number CRD42017069086).
| Search strategy and eligibility criteria
We systematically searched PubMed from inception to December 31, 2016, to identify systematic reviews and meta-analyses of observational studies examining associations between environmental risk factors and rheumatic diseases. For biomarkers, we included only serum biomarkers that are considered diagnostic markers for medical conditions. Two researchers (LB and VD) independently performed the literature search and study selection. We focused on the ten most prevalent rheumatic diseases in the US population (ie, osteoarthritis, gout, polymyalgia rheumatica, giant cell arteritis, rheumatoid arthritis, ankylosing spondylitis, Sjögren syndrome, psoriatic arthritis, systemic lupus erythematosus, systemic sclerosis/scleroderma). 30, 31 The search strategy used the following keywords:
(arthritis OR gout* OR psoriasis OR spondylitis OR lupus OR scleroderma OR osteoarthritis OR Sjogren OR arteritis OR vasculitis OR polyarteritis OR "systemic sclerosis" OR polymyalgia) AND ("systematic review" OR meta-analys*). We included meta-analyses with at least three component studies. We excluded meta-analyses that investigated the association between genetic variants and risk of rheumatic diseases. We did not apply any language restrictions in the selection of eligible studies. When more than one meta-analysis on the same association was eligible, the meta-analysis with the largest number of component cohort studies was retained for our analysis.
| Data extraction
Two researchers (LB and VD) independently performed the data extraction from eligible articles. From each eligible article, we extracted information on the first author, journal, year of publication, examined risk factors, and number of studies included. We also recorded the number of cases and controls in each component study. When the sample sizes of the component observational studies were not reported in the article of meta-analysis, we retrieved the published report of the component study and we extracted the relevant data. We recorded the study-specific relative risk estimates (ie, risk ratio, odds ratio, and hazard ratio) along with the corresponding 95% confidence intervals (CI). We also screened the component studies to ensure that none of the eligible meta-analyses included studies with overlapping population. We noted whether the eligible papers performed a qualitative assessment of component observational studies; when such an appraisal was performed, we extracted the information on this qualitative assessment.
| Statistical analyses
For each meta-analysis, we estimated the summary effect size estimate and its 95% CI using fixed-effect and random-effects models. 32, 33 For the largest study of each meta-analysis, we evaluated whether the standard error (SE) of the effect size estimate was < 0.10. If true, this denotes that the difference between the effect size estimate and the upper or lower 95% CI is <0.20, an uncertainty that is considered a small effect size.
Between-study heterogeneity was assessed and quantified by the I 2 metric. I 2 ranges between 0% and 100% and describes the percentage of total variation across studies that is due to heterogeneity rather than chance. 34 Values exceeding 50% or 75% are usually judged to represent large or very large heterogeneity, respectively. 35 We also estimated the 95% prediction interval, which further accounts for between-study heterogeneity and evaluates the uncertainty for the effect that would be expected in a new study addressing the same association. 36, 37 We applied the regression asymmetry test proposed by Egger and colleagues in order to assess whether there was evidence for small-study effects (ie, whether smaller studies tend to give substantially larger estimates of effect size compared with larger studies). 38, 39 A P < 0.10 accompanied by a more conservative effect estimate in the largest study than in random-effects meta-analysis was judged to be evidence for the presence of small-study effects.
We also applied the excess statistical significance test, which evaluates whether the observed number of studies with statistically significant results (P < 0.05) is larger than their expected number. 40 Expected number is calculated in each meta-analysis by the sum of the statistical power estimates for each component study. The true effect size for any meta-analysis is not known. We estimated the power of each component study using the effect estimate of the largest study (ie, smallest SE) in a meta-analysis. The power of each study was calculated using a non-central t distribution. Excess BELBASIS ET AL.
| 1515 statistical significance for single meta-analyses was claimed at twosided P < 0.10 with (observed number) > (expected number), as previously proposed. 41 
| Assessment of epidemiological credibility
We identified and reported the associations that had the strongest credibility and were not suggestive of bias. Specifically, we characterized as convincing the associations that met the following criteria:
had P < 1 × 10 −6 per random-effects model; were based on more than 1000 cases; had between-study heterogeneity that was not large (I 2 < 50%) and a 95% prediction interval excluding the null value; and had not evidence of small-study effects and excess significance bias. We characterized as highly suggestive the associations that had P < 1 × 10 −6 per random-effects model, were based on more than 1000 cases, and had a statistically significant effect in the largest study. Associations with P < 0.001 and a total of at least 1000 cases were characterized as suggestive. We considered as weak all other statistically significant associations. These criteria have already been applied in the field of other human diseases and contributed to the identification of risk factors with strong epidemiological credibility. [22] [23] [24] [25] [26] [27] [28] [29] For the associations with convincing or highly suggestive evidence, and as a sensitivity analysis, we assessed the study design of component studies and we performed an additional random-effects meta-analysis based only on prospective cohort studies.
The statistical analyses and power calculations were performed in STATA, version 14.0 (StataCorp LP, College Station, Texas, USA).
| RESULTS
Overall, 6079 articles were screened, and our literature search identified 30 eligible articles that examined 42 associations ( Figure 1 ).
Overall, we identified 24 unique risk factors for seven rheumatic conditions. Eight risk factors (ie, body mass index, alcohol consumption, anti-EA IgG, anti-EBNA-1 IgG, anti-VCA IgG, oral contraceptives, silica exposure, and smoking) were studied in more than one phenotype. Furthermore, body mass index (BMI) was examined as either continuous (giant cell arteritis, gout, hip osteoarthritis, knee osteoarthritis, rheumatoid arthritis) or dichotomous variable (knee osteoarthritis, rheumatoid arthritis). In the case of BMI as a dichotomous variable, two comparisons (ie, obese vs lean and overweight vs lean) were identified. In the case of smoking as a risk factor for rheumatoid arthritis, two comparisons were included (ie, ever vs never smokers and highest vs lowest quartile of pack-years among ever smokers).
The distribution of the associations by rheumatic condition is the following: rheumatoid arthritis (n = 17 associations), osteoarthritis (n = 12 associations), systemic lupus erythematosus (n = 7 associations), gout (n = 2 associations), systemic sclerosis (n = 2 associations), Sjogren syndrome (n = 1 association), and giant cell arteritis (n = 1 association). We did not capture any meta-analysis that examined risk factors for ankylosing spondylitis, polymyalgia rheumatica, and psoriatic arthritis. The median number of datasets per association was 11 (IQR, 7-13).
Twelve eligible articles, including 21 associations, used the Newcastle-Ottawa Scale to qualitatively assess the included observational studies (Table S1) . Of the 216 studies assessed, 106 (49%) were of low quality, 96 (44%) were graded as having moderate quality, and 14 (6%) were characterized as high quality. One eligible article 42 used a scoring system based on the STROBE statement. Three additional articles [43] [44] [45] used a tailor-made assessment tool.
Thirty-three associations (79%) presented a statistically significant effect at P < 0.05, 21 associations (50%) remained statistically significant at P < 0.001, and 13 associations (31%) remained significant at P < 1 × 10 −6 (Table 1 ). In 20 associations (48%), the largest study had a SE of < 0.10. The result of the largest study was more conservative than the summary result of meta-analysis in 29 associations (69%).
Ten associations (24%) had small or moderate between-study heterogeneity estimates (I 2 < 50%), 15 associations (36%) had large heterogeneity estimates, whereas 17 associations (40%) had very large heterogeneity estimates (I 2 > 75%). Only three associations (7%) had a 95% prediction interval that excluded the null value.
These associations pertained to BMI and risk for gout, knee extensor muscle weakness and risk for knee osteoarthritis, and smoking and risk for rheumatoid arthritis. Evidence for small-study effects was present in nine associations (21%). Also, hints for excess statistical significance were found in six associations (14%). Excess significance test could not be performed in 15 associations, because study-specific sample sizes were not available for these associations.
By applying a standardized procedure, we identified one association (2%) that was supported by convincing evidence. Specifically, pack-years of smoking had robust evidence of association as a risk factor for rheumatoid arthritis. Furthermore, eight associations (19%)
were supported by highly suggestive evidence. These associations pertained to BMI (per 5 kg/m 2 increase) as a risk factor for gout and hip osteoarthritis, alcohol as risk factor for gout, BMI (overweight vs lean, and obese vs lean), knee injury and participation in heavy work as risk factors for knee osteoarthritis, and smoking (ever vs never smokers) as a risk factor for rheumatoid arthritis. Additionally, six associations (14%) were supported by suggestive evidence, whereas 18 associations (43%) presented weak evidence. Nine associations (22%) did not present a statistically significant effect (Table 1) .
For three associations (ie, an association on BMI as a continuous exposure and risk for gout, and two associations on BMI as a dichotomous variable and risk for knee osteoarthritis), only prospective cohort studies were included in the respective meta-analyses.
When we focused in prospective cohort studies only, the association of smoking quantity among ever smokers and risk for rheumatoid arthritis presented highly suggestive evidence due to a 95% prediction interval including the null value. Furthermore, four highly suggestive associations (ie, alcohol consumption and risk for gout, BMI and risk for hip osteoarthritis, knee injury and risk for knee osteoarthritis, and smoking and risk for rheumatoid arthritis) were downgraded to suggestive only, because they presented a P-value >1 × 10 −6 in the sensitivity analysis. Another one highly suggestive association (ie, participation in heavy work and risk for knee osteoarthritis) was graded as weak, because it presented a P-value >0.001 in the sensitivity analysis. The results of the sensitivity analysis of prospective cohort studies are presented in Table 2 .
| DISCUSSION
In the present umbrella review, we summarized and critically appraised the evidence on 42 associations of risk factors with the most prevalent rheumatic diseases. As shown in this paper, even though almost 80%
of the examined associations presented a statistically significant effect at P < 0.05, only around 20% of the associations provided convincing or highly suggestive evidence using our approach where the strength of evidence, potential biases, and the epidemiological credibility using predefined criteria were assessed. In summary, higher alcohol consumption was linked with increased risk for gout. Also, obesity was associated with increased risk for hip and knee osteoarthritis, and gout. Similarly, subjects exposed to heavy work and previous knee injury had increased risk for development of knee osteoarthritis, whereas tobacco smoking and pack-years of smoking were both strongly associated with higher risk for rheumatoid arthritis.
Researchers widely use a P-value threshold at the level of P < 0.05 to claim discoveries of novel findings. However, in several cases, evidence based on this threshold can only constitute weak evidence and there are ongoing discussions to redefine the level of statistical significance using more stringent criteria. 46, 47 Previously published umbrella reviews mapped the evidence for risk factors of neurodegenerative diseases, [22] [23] [24] [25] skin cancers, 26 schizophrenia, 28 and type 2 diabetes mellitus, 29 and they indicated a similar picture for epidemiological credibility. In general, at least half of the examined associations were statistically significant at P < 0.05. However, only a small portion of these associations survived and achieved high credibility level after the application of the prespecified methodological criteria.
Interestingly, our systematic search did not capture any published meta-analysis on risk factors for ankylosing spondylitis, polymyalgia rheumatica, and psoriatic arthritis. Also, we did not identify any robust associations for giant cell arteritis, Sjögren syndrome, systemic lupus erythematosus, and systemic sclerosis. Indeed, almost two-thirds of the identified associations examined risk factors for osteoarthritis, rheumatoid arthritis, and gout, which are the most prevalence rheumatic diseases. It seems apparent that the main drive guiding the investigation of risk factors is the prevalence of the rheumatic disease.
Our umbrella review showed that obesity and high alcohol consumption are both strongly associated with risk for gout. Although large heterogeneity was observed for BMI, the 95% prediction intervals excluded the null value and we did not observe any evidence for small-study effects or excess significance bias. Gout is a common form of inflammatory arthritis and its central pathological feature is chronic deposition of monosodium urate crystals. 48 The main risk factor for development of gout is hyperuricaemia, and it is suggested that environmental risk factors modify the risk for gout by affecting serum uric acid level. 48 Thus, obesity and alcohol consumption may increase the risk of gout by increasing serum uric acid level. 49 Regarding alcohol consumption, the association with risk for gout was characterized by very large between-study heterogeneity, and a 95% prediction interval including the null value. Given that alcohol consumption has been associated with serum uric acid levels, 50 this large heterogeneity could be partially explained by the fact that different alcoholic beverages exert a differential effect on serum uric acid levels. 50 We should also pinpoint that even though heavy alcohol consumption was associated with a more than twofold increase in the risk for gout, the observed effect could probably be inflated due to evidence for small-study effects and excess significance bias.
We also showed strong epidemiological credibility for the association between smoking and risk for rheumatoid arthritis. Ever smokers had higher risk for rheumatoid arthritis than never smokers, 45 but very large between-study heterogeneity, evidence for smallstudy effects and excess significance bias were observed. When the analysis focused on smokers only, convincing evidence was found that individuals in the highest quartile of pack-years had a 2-fold increase in risk for rheumatoid arthritis compared to individuals in the lowest quartile 51 with no potential biases that could affect the observed association. Of note, a previous umbrella review showed that smoking is also strongly associated with risk for multiple sclerosis, 22 an observation implying that smoking has a strong effect on the development of autoimmune conditions. Furthermore, our stringent evaluation identified one risk factor for hip osteoarthritis (ie, BMI) and three risk factors for knee osteoarthritis (ie, BMI, knee injury, and exposure to heavy work). An The association between pack-years of smoking and risk for rheumatoid arthritis presented convincing evidence in the main analysis. The remaining associations presented highly suggestive evidence in the main analysis. BMI, body mass index; CI, confidence interval; NA, not available; OR, odds ratio; PI, prediction interval.
increase in risk for both hip and knee osteoarthritis was observed per 5 kg/m 2 increase in BMI. Two mechanisms have been suggested for the involvement of obesity in the pathogenesis of osteoarthritis.
Obesity increases the load on weight-bearing joints, but it might also increase joint susceptibility through the action of inflammatory adipokines. 52 Also, the main theory for the pathogenesis of osteoarthritis is associated with bone or cartilage damage. Indeed, in our umbrella review, we identified knee injury as a highly suggestive risk factor and it is evident that knee injury directly makes the joint more susceptible to further insult affecting joint biomechanics. 52 Furthermore, individuals participating in heavy work exerted an increased risk for knee osteoarthritis probably due to their exposure to working conditions favouring knee injuries and heavy load on their knees.
Even though we identified meta-analyses that examined risk factors for systemic lupus erythematosus and systemic sclerosis, we did not find any risk factor supported by convincing or highly suggestive evidence. Two risk factors were supported by suggestive evidence:
smoking and silica exposure. Specifically, smoking was associated with elevated risk for systemic lupus erythematosus, 53 but this association had a P > 1 × 10 −6 and a 95% prediction interval including the null value. It is possible that additional evidence from future studies could improve the epidemiological credibility of this association. Smoking had also been strongly associated with other immunemediated diseases, such as rheumatoid arthritis and multiple sclerosis. 22, 45, 51, 54 We also found that silica exposure was associated with increased risk for systemic sclerosis, 55 and this association was supported by suggestive evidence with very large between-study heterogeneity and absence of further support by the largest study. 56 Our study has some caveats. First, we did not conduct a qualitative assessment of component studies, because this was beyond the scope of the present study. The quality of component studies should be assessed in the original systematic reviews and meta-analyses through standardized tools, such as the Newcastle-Ottawa scale.
However, when a qualitative assessment was available through the eligible articles, we extracted this information. Second, we considered only associations that have been examined in a meta-analysis and, therefore, we may have missed some published associations that have been supported by a small number of studies. Third, the observational studies included in the eligible meta-analyses were not always clearly reporting the sample sizes of component studies, and in some cases, the sample sizes were not reported at all. Thus, the power calculations and the extent of excess significance bias are conservative. In some cases, we could not perform the excess significance test due to absence of study-specific sample sizes.
In the present umbrella review, we examined the epidemiological credibility of environmental risk factors for the most prevalent rheumatic diseases, as reported by meta-analyses of observational studies.
Although we included 10 medical conditions, only 42 associations were identified. This observation indicates that, although rheumatic diseases are quite prevalent in the general population, the epidemiology of these conditions has attracted small scientific interest. Overall, we identified risk factors that are associated with gout, osteoarthritis, and rheumatoid arthritis and have showed robust epidemiological evidence. These findings can guide future gene-environment and Mendelian randomization studies, expanding our knowledge on genetic and environmental associations for rheumatic diseases.
CONFLI CT OF INTERESTS
None.
O R C I D

Evangelos Evangelou
http://orcid.org/0000-0002-5488-2999
